Literature DB >> 18633612

Risk factors for osteonecrosis of the femoral head in patients with sickle cell disease.

A L Akinyoola1, I A Adediran, C M Asaleye, A R Bolarinwa.   

Abstract

The mechanisms involved in the pathogenesis of osteonecrosis of the femoral head in sickle cell disease are not fully known. The aim of this study was to identify risk factors for osteonecrosis of the femoral head among sickle cell disease patients. Clinical (frequency of painful crises and hospitalisation) and laboratory parameters (euglobulin clot lysis time, haematocrit, platelet count, and leucocyte count) of 25 consecutive patients with avascular necrosis of the femoral head from sickle cell disease were compared with those of 26 age- and sex-matched sickle cell disease patients without avascular necrosis. The group with avascular necrosis of the femoral head (mean age 23.7+/-4.9 years) had a significantly higher rate of painful crises (p = 0.03) and hospitalisations per year (p = 0.002) than the group without avascular necrosis (mean age 21.6+/-5.2 years). The group with avascular necrosis also had a significantly higher euglobulin clot lysis time than the group without avascular necrosis (p = 0.001). In conclusion, it appears that not all patients with sickle cell disease have impaired fibrinolytic activity. The aetiology of avascular necrosis in sickle cell disease is multifactorial.

Entities:  

Mesh:

Year:  2008        PMID: 18633612      PMCID: PMC2898987          DOI: 10.1007/s00264-008-0584-1

Source DB:  PubMed          Journal:  Int Orthop        ISSN: 0341-2695            Impact factor:   3.075


  18 in total

1.  Procoagulants and osteonecrosis.

Authors:  Lynne C Jones; Michael A Mont; Tung B Le; Michelle Petri; David S Hungerford; Ping Wang; Charles J Glueck
Journal:  J Rheumatol       Date:  2003-04       Impact factor: 4.666

2.  Plasma fibrinolytic activity in sickle cell disease.

Authors:  A A Famodu
Journal:  Trop Geogr Med       Date:  1988-10

3.  Haematological factors associated with avascular necrosis of the femoral head in homozygous sickle cell disease.

Authors:  H Hawker; H Neilson; R J Hayes; G R Serjeant
Journal:  Br J Haematol       Date:  1982-01       Impact factor: 6.998

4.  Natural coagulation inhibitors (protein C, protein S, antithrombin) in patients with sickle cell anemia in a steady state.

Authors:  A K Bayazit; Y Kilinç
Journal:  Pediatr Int       Date:  2001-12       Impact factor: 1.524

5.  Role of thrombotic and fibrinolytic disorders in the etiology of Perthes' disease.

Authors:  Kyung-Hoi Koo; Hae-Ryong Song; Yong-Chan Ha; Jang-Rak Kim; Seon-Ju Kim; Kang-I I Kim; Ki Churl Chang; In-Oak Ahn; Se-Hyun Cho
Journal:  Clin Orthop Relat Res       Date:  2002-06       Impact factor: 4.176

6.  Avascular necrosis of the femoral head in sickle cell disease in Nigeria: a retrospective study.

Authors:  A L Akinyoola; I A Adediran; C M Asaleye
Journal:  Niger Postgrad Med J       Date:  2007-09

7.  Thrombotic and fibrinolytic alterations in the aseptic necrosis of femoral head.

Authors:  Emoke Pósán; Kálmán Szepesi; Levente Gáspár; Zoltán Csernátony; Jolán Hársfalvi; Eva Ajzner; Anikó Tóth; Miklós Udvardy
Journal:  Blood Coagul Fibrinolysis       Date:  2003-04       Impact factor: 1.276

8.  Avascular necrosis of the femoral head in sickle-cell disease. A series from the Guinea Savannah of Nigeria.

Authors:  C G Iwegbu; A F Fleming
Journal:  J Bone Joint Surg Br       Date:  1985-01

9.  Role of thrombotic and fibrinolytic disorders in osteonecrosis of the femoral head.

Authors:  Jong-Suk Lee; Kyung-Hoi Koo; Yong-Chan Ha; Kwang Kon Koh; Seon Ju Kim; Jang-Rak Kim; Hae-Ryong Song; Se-Hyun Cho
Journal:  Clin Orthop Relat Res       Date:  2003-12       Impact factor: 4.176

10.  Prevalence, clinical features, and risk factors of osteonecrosis of the femoral head among adults with sickle cell disease.

Authors:  M Mukisi-Mukaza; A Elbaz; Y Samuel-Leborgne; L Kéclard; C Le Turdu-Chicot; E Christophe-Duchange; G Mérault
Journal:  Orthopedics       Date:  2000-04       Impact factor: 1.390

View more
  22 in total

1.  Tardive hip disease diagnosis in a young adult with sickle cell disease.

Authors:  A A Bokolombe; F Samato; T Lukinu; M B Ekila; M N Aloni
Journal:  Afr Health Sci       Date:  2013-03       Impact factor: 0.927

2.  Chronic Opioid Therapy and Central Sensitization in Sickle Cell Disease.

Authors:  C Patrick Carroll; Sophie Lanzkron; Carlton Haywood; Kasey Kiley; Megan Pejsa; Gyasi Moscou-Jackson; Jennifer A Haythornthwaite; Claudia M Campbell
Journal:  Am J Prev Med       Date:  2016-07       Impact factor: 5.043

3.  Histopathology of aseptic necrosis of the femoral head in sickle cell disease.

Authors:  Martin Mukisi-Mukaza; Anne Gomez-Brouchet; Monique Donkerwolcke; Maurice Hinsenkamp; Franz Burny
Journal:  Int Orthop       Date:  2010-09-10       Impact factor: 3.075

4.  Symptomatic Avascular Necrosis: An Understudied Risk Factor for Acute Care Utilization by Patients with SCD.

Authors:  Tiffany Yu; Timothy Campbell; Isabella Ciuffetelli; Carlton Haywood; Christopher Patrick Carroll; Linda Resar; John J Strouse; Sophie Lanzkron
Journal:  South Med J       Date:  2016-09       Impact factor: 0.954

5.  Hemoglobin to Hematocrit Ratio: The Strongest Predictor of Femoral Head Osteonecrosis in Children With Sickle Cell Disease.

Authors:  Douglas Worrall; Kim Smith-Whitley; Lawrence Wells
Journal:  J Pediatr Orthop       Date:  2016-03       Impact factor: 2.324

6.  Treatment with acetylsalicylic acid prevents short to mid-term radiographic progression of nontraumatic osteonecrosis of the femoral head: a pilot study.

Authors:  Anthony Albers; Alberto Carli; Bertrand Routy; Edward J Harvey; Chantal Séguin
Journal:  Can J Surg       Date:  2015-06       Impact factor: 2.089

7.  Umbrella-shaped, memory alloy femoral head support device for treatment of avascular osteonecrosis of the femoral head.

Authors:  Xiaowei Yu; Wenxiong Jiang; Qi Pan; Tianyi Wu; Yan Zhang; Zubin Zhou; Dongpeng Du
Journal:  Int Orthop       Date:  2013-03-27       Impact factor: 3.075

8.  Vascularised greater trochanter bone graft, combined free iliac flap and impaction bone grafting for osteonecrosis of the femoral head.

Authors:  Yi-Rong Zeng; Sheng He; Wen-Jun Feng; Fei-long Li; Jie Li; Lin-Yang Jian; Jian-Chun Zeng; Yue-Guang Fan
Journal:  Int Orthop       Date:  2013-01-23       Impact factor: 3.075

Review 9.  Beyond the definitions of the phenotypic complications of sickle cell disease: an update on management.

Authors:  Samir K Ballas; Muge R Kesen; Morton F Goldberg; Gerard A Lutty; Carlton Dampier; Ifeyinwa Osunkwo; Winfred C Wang; Carolyn Hoppe; Ward Hagar; Deepika S Darbari; Punam Malik
Journal:  ScientificWorldJournal       Date:  2012-08-01

10.  Clinical and radiological outcomes of treatment of avascular necrosis of the femoral head using autologous osteochondral transfer (mosaicplasty): preliminary report.

Authors:  Jacek Gagala; Marta Tarczyńska; Krzysztof Gawęda
Journal:  Int Orthop       Date:  2013-05-01       Impact factor: 3.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.